Braftovi is a prescription medication used in the treatment of certain types of cancer, specifically melanoma. It belongs to a class of drugs known as kinase inhibitors, which work by blocking the action of certain proteins that are involved in the growth and spread of cancer cells.
This medication is typically used in combination with other cancer treatments, such as immunotherapy or chemotherapy, to help improve outcomes for patients with advanced melanoma. Braftovi is taken orally in the form of a tablet, usually once a day with or without food, as directed by a healthcare provider.
As with any medication, Braftovi may cause side effects. Common side effects may include nausea, vomiting, diarrhea, fatigue, and skin rash. It is important to report any side effects to your healthcare provider, as they may be able to provide guidance on how to manage them.
It is also important to follow your healthcare provider’s instructions carefully when taking Braftovi. This may include regular blood tests to monitor your body’s response to the medication and to adjust the dosage as needed.
Overall, Braftovi has shown promising results in the treatment of melanoma and has provided new hope for patients with this aggressive form of cancer. If you have been prescribed Braftovi, it is important to work closely with your healthcare team to ensure the best possible outcomes.
EN 
ES 
FR 
PT 
ZH